{"brief_title": "Dose Confirmation Efficacy Study (V260-007)", "brief_summary": "This study was designed to evaluate the safety of the investigational Rotavirus Vaccine and the efficacy to prevent Rotavirus Gastroenteritis.", "detailed_description": "The duration of treatment is 10 months.", "condition": "Rotavirus Infections", "intervention_type": "Biological", "intervention_name": "Comparator: Placebo matching RotaTeq\u2122", "description": "Placebo matching RotaTeq\u2122 administered 28 to 70 days apart.", "arm_group_label": "Placebo matching RotaTeq\u2122", "other_name": "V260", "criteria": "Inclusion Criteria: - Healthy infants Exclusion Criteria: - History of abdominal disorders from a birth defect, intussusception, or abdominal surgery - Known or suspected problems with immune system - Fever at time of immunization - Prior administration of a rotavirus vaccine - History of known prior rotavirus disease - Chronic diarrhea, or failure to thrive", "gender": "All", "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "healthy_volunteers": "Accepts Healthy Volunteers", "id": "NCT00092443.xml"}